Lupin introduces generic Glucagon for Injection USP in the US market. Bioequivalent to Eli Lilly's, used for hypoglycemia ...

A transformative moment in the global fight against obesity has emerged with the announcement of positive topline results ...

Buck up, baby boomers. Sixty may not be the new 40, but 80 could soon be the new 60. A trove of new Alzheimer’s research ...

Global pharma major Lupin Limited (Lupin) announced the launch of glucagon for injection USP, 1mg/vial packaged in an emergency kit in the United States. Glucagon for injection USP, 1mg/vial packaged ...

Here are five oral obesity candidates that, according to Mizuho’s Graig Suvannavejh, could change the weight loss game.

Large-cap laggards slid on weak results/guidance, cuts and capital moves—led by The Trade Desk, Fortinet, Super Micro, ...

A legacy ranch in Jackson Hole, WY, has come onto the market, with records showing it is owned by former Eli Lilly exec Dr.

The initiative, titled 'The Court Is Hers,' eliminates registration fees for girls basketball programs at the YMCA.

Pfizer ( PFE) shares gained on Tuesday after the New York-based pharma giant reported better-than-expected financials for Q2 2025 and increased its full-year earnings outlook, citing, among other ...

On August 9, Fundstrat’s Tom Lee appeared on CNBC to discuss the current state of the market and the potential for further ...

Eli Lilly says their obesity pill led to more than 12% weight loss in closely watched late-stage trial, paving way for ...

Now, Eli Lilly says its experimental GLP-1 pill is a success after the first phase-three trial. The company said more than 3,000 adults on the experimental oral medication lowered their weight by an ...